Bristol-Myers Squibb Co (NYSE:BMY)
| 62.99 BATS BZX Real-Time Price As of 12:59pm ET |  +0.15 / +0.24%Today’s Change | 45.76 Today|||52-Week Range 68.34 | -1.87% Year-to-Date |
Latest BMY News | Press Releases
Today’s Trading
| Previous close | 62.84 |
| Today’s open | 63.20 |
| Day’s range | 62.89 - 63.69 |
| Volume | 3,190,583 |
| Average volume (3 months) | 10,261,320 |
| Market cap | $139.2B |
Data as of 12:59pm ET, 11/27/2020
Growth & Valuation
| Earnings growth (last year) | -33.05% |
| Earnings growth (this year) | +35.71% |
| Earnings growth (next 5 years) | +9.95% |
| Revenue growth (last year) | +15.89% |
| P/E ratio | NM |
| Price/Sales | 4.20 |
| Price/Book | 2.66 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LLYEli Lilly and Co | +2.78 | +1.92% |
| AZNAstraZeneca | +0.01 | +0.02% |
| SNYSanofi | +0.83 | +1.65% |
| NVONovo Nordisk | +1.34 | +2.03% |
Data as of 12:59pm ET, 11/27/2020
Financials
| Next reporting date | January 28, 2021 |
| EPS forecast (this quarter) | $1.40 |
| Annual revenue (last year) | $26.1B |
| Annual profit (last year) | $3.4B |
| Net profit margin | 13.15% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
